{
  "id": "621218353a8413c653000013",
  "type": "yesno",
  "question": "Is REGN5458 a single-targeted antibody?",
  "ideal_answer": "No, REGN5458 is a bispecific antibody.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/33651100"
  ],
  "snippets": [
    {
      "text": "CD3-engaging bispecific antibodies (bsAbs) and chimeric antigen receptor (CAR) T cells are potent therapeutic approaches for redirecting patient T cells to recognize and kill tumors. Here we describe a fully human bsAb (REGN5458) that binds to B-cell maturation antigen (BCMA) and CD3, and compare its antitumor activities vs those of anti-BCMA CAR T cells to identify differences in efficacy and mechanism of action. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33651100",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}